Titre : Caulobacteraceae

Caulobacteraceae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Paranoid Disorders

Questions fréquentes et termes MeSH associés

Général 1

#1

Erreur lors de la génération.

Veuillez réessayer ultérieurement.
Caulobacteraceae
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Caulobacteraceae : Questions médicales les plus fréquentes", "headline": "Caulobacteraceae : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Caulobacteraceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-19", "dateModified": "2025-02-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Caulobacteraceae" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Alphaproteobacteria", "url": "https://questionsmedicales.fr/mesh/D020561", "about": { "@type": "MedicalCondition", "name": "Alphaproteobacteria", "code": { "@type": "MedicalCode", "code": "D020561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.050" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Caulobacter", "alternateName": "Caulobacter", "url": "https://questionsmedicales.fr/mesh/D016934", "about": { "@type": "MedicalCondition", "name": "Caulobacter", "code": { "@type": "MedicalCode", "code": "D016934", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.050.090.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Caulobacter crescentus", "alternateName": "Caulobacter crescentus", "url": "https://questionsmedicales.fr/mesh/D016935", "about": { "@type": "MedicalCondition", "name": "Caulobacter crescentus", "code": { "@type": "MedicalCode", "code": "D016935", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.050.090.100.100" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Caulobacteraceae", "alternateName": "Caulobacteraceae", "code": { "@type": "MedicalCode", "code": "D042063", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xiaojun Yang", "url": "https://questionsmedicales.fr/author/Xiaojun%20Yang", "affiliation": { "@type": "Organization", "name": "College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China." } }, { "@type": "Person", "name": "Yuanping Li", "url": "https://questionsmedicales.fr/author/Yuanping%20Li", "affiliation": { "@type": "Organization", "name": "Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China." } }, { "@type": "Person", "name": "Renwei Feng", "url": "https://questionsmedicales.fr/author/Renwei%20Feng", "affiliation": { "@type": "Organization", "name": "Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China." } }, { "@type": "Person", "name": "Jian Chen", "url": "https://questionsmedicales.fr/author/Jian%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Cellular Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA." } }, { "@type": "Person", "name": "Hend A Alwathnani", "url": "https://questionsmedicales.fr/author/Hend%20A%20Alwathnani", "affiliation": { "@type": "Organization", "name": "Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Paranoid thinking and perceived competitive intention.", "datePublished": "2023-03-10", "url": "https://questionsmedicales.fr/article/36923500", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj.15003" } }, { "@type": "ScholarlyArticle", "name": "Rethinking paranoid ideation and reasoning: A pilot study based on the argumentative theory of reasoning.", "datePublished": "2023-05-27", "url": "https://questionsmedicales.fr/article/37307645", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbtep.2023.101884" } }, { "@type": "ScholarlyArticle", "name": "Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial.", "datePublished": "2022-08-15", "url": "https://questionsmedicales.fr/article/35971137", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06614-0" } }, { "@type": "ScholarlyArticle", "name": "Experimental studies of paranoid thinking in clinical and nonclinical populations: a systematic review and meta-analysis.", "datePublished": "2023-07-10", "url": "https://questionsmedicales.fr/article/37427557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/S0033291723001708" } }, { "@type": "ScholarlyArticle", "name": "A randomised controlled test in virtual reality of the effects on paranoid thoughts of virtual humans' facial animation and expression.", "datePublished": "2024-07-24", "url": "https://questionsmedicales.fr/article/39048648", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-67534-4" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Bactéries", "item": "https://questionsmedicales.fr/mesh/D001419" }, { "@type": "ListItem", "position": 3, "name": "Proteobacteria", "item": "https://questionsmedicales.fr/mesh/D020560" }, { "@type": "ListItem", "position": 4, "name": "Alphaproteobacteria", "item": "https://questionsmedicales.fr/mesh/D020561" }, { "@type": "ListItem", "position": 5, "name": "Caulobacteraceae", "item": "https://questionsmedicales.fr/mesh/D042063" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Caulobacteraceae - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Caulobacteraceae", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Caulobacteraceae", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D042063?mesh_terms=Paranoid+Disorders#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 13/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Xiaojun Yang

1 publication dans cette catégorie

Affiliations :
  • College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Yuanping Li

1 publication dans cette catégorie

Affiliations :
  • Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Renwei Feng

1 publication dans cette catégorie

Affiliations :
  • Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Jian Chen

1 publication dans cette catégorie

Affiliations :
  • Department of Cellular Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Publications dans "Caulobacteraceae" :

Hend A Alwathnani

1 publication dans cette catégorie

Affiliations :
  • Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Publications dans "Caulobacteraceae" :

Weifeng Xu

1 publication dans cette catégorie

Affiliations :
  • Joint International Research Laboratory of Water and Nutrient in Crop, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Christopher Rensing

1 publication dans cette catégorie

Affiliations :
  • Institute of Environmental Microbiology, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Publications dans "Caulobacteraceae" :

Sources (10000 au total)

Rethinking paranoid ideation and reasoning: A pilot study based on the argumentative theory of reasoning.

Cognitive theories assume an imbalance of intuitive and analytical reasoning in paranoid ideation. The argumentative theory of reasoning offers an approach on the primary function of reasoning and its... 327 participants completed the Social Network Index (SNI), the Paranoia Checklist (PCL), and the Cognitive Reflection Test-2 (CRT2). Moreover, preference and frequency of discussions were assessed. In... The discussion group showed lower distorted reflective reasoning than the control group. Discussion preference and/or frequency was associated with frequency and disturbance of paranoid thoughts, as w... Due to the online format environmental factors could not be held constant and no intrasubject comparison of the CRT2 could be computed in the trial. Furthermore, the sample mainly consisted of psychol... The results contribute to the understanding of distorted reflective reasoning and provides preliminary evidence that the argumentative theory of reasoning may offer a promising perspective for delusio...

Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial.

Schizophrenia spectrum disorders cause suffering for patients, relatives, and the surrounding society. Paranoid ideations, encompassing ideas of social reference and manifest persecutory delusions, ar... This study is a randomized, assessor-blinded parallel-groups multi-center superiority clinical trial, fulfilling the CONSORT criteria for non-pharmacological treatment. A total of 256 patients diagnos... The trial will elucidate whether VR-CBT can enhance therapy efficacy for paranoid ideations. Additionally, Trial findings will provide evidence on the effectiveness and cost-effectiveness of VR-CBT fo... ClinicalTrials.gov NCT04902066 . Initial release April 9th, 2021....

"Green et al. Paranoid Thoughts Scale-revised": Structural invariance and clinical utility of a brief version in schizophrenia.

Persecutory ideas are highly frequent in psychotic disorders and particularly in schizophrenia. Although several measures exist to assess persecutory ideas in both clinical and non-clinical samples, t... 100 individuals with schizophrenia and 72 non-clinical controls were recruited. We used the GPTS-8, a brief 8-item version of the R-GPTS recently developed and validated in the French general populati... Confirmatory factor analysis supported the original two-factor structure (social reference and persecution subscales) of the GPTS-8. The GPTS-8 was positively and moderately correlated with the Positi... The French GPTS 8-item brief scale-8 retains the psychometric strengths of the R-GPTS in schizophrenia with relevant clinical validity. The GPTS-8 can consequently be used as a short and quick measure...

The reliability and validity of the revised Green et al. paranoid thoughts scale in individuals at clinical high-risk for psychosis.

Paranoia is a common and impairing psychosis symptom, which exists along a severity continuum that extends into the general population. Individuals at clinical high-risk for psychosis (CHR) frequently... Participants were CHR individuals (n = 103), mixed clinical controls (n = 80), and healthy controls (n = 71) who completed self-report and interview measures. Confirmatory factor analysis (CFA), psych... CFA replicated a two-factor structure for the RGPTS and the associated reference and persecution scales were reliable. CHR individuals scored significantly higher on both reference and persecution, re... These results demonstrate the reliability and validity of the RGPTS, though its scales related more weakly to severity in CHR individuals. The RGPTS may be useful in future work aiming to develop symp...

Cognitive bias modification for paranoia (CBM-pa): a randomised controlled feasibility study in patients with distressing paranoid beliefs.

Cognitive Bias Modification for paranoia (CBM-pa) is a novel, theory-driven psychological intervention targeting the biased interpretation of emotional ambiguity associated with paranoia. Study object... In a double-blind randomised controlled trial, sixty-three outpatients with clinically significant paranoia were randomised to either CBM-pa or an active control (text reading) between April 2016 and ... A total of 122 patients were screened and 63 were randomised. The recruitment rate was 51.2%, with few dropouts (four out of 63) and follow-up rates were 90.5% (1-month) and 93.7% (3-months). Each ses... CBM-pa is feasible for patients with paranoia. A fully powered randomised control trial is warranted....